{"paper_id":"609219a4-aac7-492a-81d1-ef9edd8467aa","body_text":"In Vitro Effects of a Small-Molecule Antagonist of the Tcf/ß-Catenin Complex on Endometrial and Endometriotic Cells of Patients with Endometriosis\nFigure 6\nEffects of PKF 115–584 on cell proliferation.\nA, B: Basal cell proliferation in non-treated epithelial (A) and stromal (B) cells of endometriotic tissue and matched eutopic endometrium of the same patients. C, D: Percent inhibition of cell proliferation in epithelial (C) and stromal (D) cells of endometriotic tissue and matched eutopic endometrium of the same patients treated with PKF 115–584. Results are presented as the mean+SEM. Basal cell proliferation is presented as OD. Percent inhibition of cell proliferation is calculated as percent of vehicle control. P: proliferative phase, S: secretory phase. DE: deep infiltrating endometriosis (epithelial cells: P: n = 7, S: n = 8; stromal cells: P: n = 7, S:n = 9 ). OE: ovarian endometriosis (epithelial cells: P: n = 7 S: n = 6; stromal cells: P: n = 7, S: n = 8 ). SE: superficial peritoneal endometriosis (epithelial cells: P: n = 6, S: n = 6; stromal cells: P: n = 6, S: n = 7 ). A: p<.05 versus matched eutopic endometrium of the same patients.","source_license":"CC0","license_restricted":false}